The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.

Ricardo DonnersNina TunariuHolly ToveyEmma HallSue ChuaGary CookYong DuMatthew D BlackledgeChristopher C ParkerDow-Mu Koh

Published in: European radiology (2023)

• 18F-sodium fluoride PET baseline SUVmax of castration-resistant prostate cancer bone metastases showed significant association with response to radium-223. • Baseline 18F-sodium fluoride PET can improve patient selection for radium-223 therapy. • Change in whole-body DWI parameters can be used for response correlation with baseline 18F-sodium fluoride PET SUVmax in castration-resistant prostate cancer bone metastases.

Keyphrases

pet ct
drinking water
positron emission tomography
computed tomography
pet imaging
magnetic resonance imaging
case report
stem cells